about
Melatonin for the prevention and treatment of cancerMelatonin as a Promising Agent to Treat Ovarian Cancer: Molecular Mechanisms.Evaluating the associations between human circadian rhythms and dysregulated genes in liver cancer cells.Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control studyMelatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Urinary melatonin and risk of ovarian cancer
@ast
Urinary melatonin and risk of ovarian cancer
@en
Urinary melatonin and risk of ovarian cancer
@nl
type
label
Urinary melatonin and risk of ovarian cancer
@ast
Urinary melatonin and risk of ovarian cancer
@en
Urinary melatonin and risk of ovarian cancer
@nl
prefLabel
Urinary melatonin and risk of ovarian cancer
@ast
Urinary melatonin and risk of ovarian cancer
@en
Urinary melatonin and risk of ovarian cancer
@nl
P2093
P2860
P1476
Urinary melatonin and risk of ovarian cancer
@en
P2093
Elizabeth M Poole
Eva Schernhammer
Leigha Mills
Susan E Hankinson
P2860
P2888
P304
P356
10.1007/S10552-015-0640-2
P407
P577
2015-10-01T00:00:00Z